Bile Acids in Hepatobiliary Disease
T.C. Northfield, H. Ahmed, R. Jazwari, P. Zentler-Munro
Springer Science & Business Media, Feb 29, 2000 - Medical - 339 pages
This book is the proceedings of the Falk Workshop on `Bile Acids in Hepatobiliary Disease', which took place at the Royal Society of Medicine (RSM) in London, UK, on 29-30 March 1999, and was held in association with the Section of Measurement in Medicine at the RSM.
The main interest in bile acid therapy has been recently in cholestatic liver disease. The proceedings of the workshop not only discusses this, but moves on to examine its possible use in alcoholic liver disease, and moves back to re-examine its role in biliary disease. Leading world experts attempt to define its mechanism of action, and the current role of other non-surgical treatments in biliary disease. The physiology and pathogenesis of cholestatic and alcoholic liver disease and cholesterol gallstone disease is also examined.
What people are saying - Write a review
We haven't found any reviews in the usual places.
acetaldehyde acromegaly activity alcoholic liver disease bile acid therapy bile acid transporter bile duct bile salt biliary lipid bilirubin biochemical canalicular cancer CDCA cells CF patients chenodeoxycholic acid cholecystectomy cholestasis cholesterol cholesterol gallstone cholic acid chronic ethanol Clin Invest clinical collagen colonic concentration conjugated bile acids consumption cystic fibrosis decreased dehydrogenase deoxycholic acid dietary dose effect of ursodeoxycholic enterohepatic ethanol factors faecal fat absorption fatty acids Figure function gallbladder gallstone gallstone disease gallstone dissolution gallstone formation gallstone recurrence Gastroenterol Gastroenterology gene genetic hepatocyte Hepatol Hepatology Hofmann human ileal impaired increased induced inhibition intake intestinal laparoscopic levels Lieber lipid malabsorption markers membrane metabolism microsomal mixed micelles molecules MTBE normal octreotide oxidation pathogenesis Paumgartner G phospholipid placebo plasma primary biliary cirrhosis protein rat liver reduced role secretion serum solubilization stones taurine toxicity transit treatment trial UDCA uptake ursodeoxycholic acid vitamin vitro